Clinical toxicity and laboratory effects of granulocyte-colony- stimulating factor (filgrastim) mobilization and blood stem cell apheresis from normal donors, and analysis of charges for the procedures

Transfusion

Volumn 36, Issue 7, 1996, Pages 590-595

  Anderlini, P ^a   Przepiorka, D ^a   Seong, D ^a   Miller, P ^a   Sundberg, J ^a   Lichtiger, B ^a   Norfleet, F ^a   Chan, K W ^a   Champlin, R ^a   Korbling M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; LACTATE DEHYDROGENASE; MAGNESIUM; POTASSIUM; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; URIC ACID;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; APHERESIS; ARTICLE; BONE PAIN; CHILD; DONOR; FATIGUE; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAGNESIUM BLOOD LEVEL; MALE; NAUSEA; POTASSIUM BLOOD LEVEL; STEM CELL TRANSPLANTATION; URIC ACID BLOOD LEVEL;

EID: 3042940036     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36796323057.x     Document Type: Article

References (22)

1. Körbling M, Fliedner TM, Calvo W, et al. Albumin density gradient purification of canine hemopoietic blood stem cells (HBSC): long-term allogeneic engraftment without GVH-reaction. Exp Hematol 1979;7:277-88.
2. Kessinger A, Smith DM, Strandjord SE, et al. Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989;4:643-6.
3. Körbling M, Przepiorka D, Huh YO, et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995;85:1659-65.
4. Schmitz N, Dreger P, Suttorp M, et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 1995;85:1666-72.
5. Bensinger WI, Weaver CH, Appelbaum FR, et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1995;85:1655-8.
6. Suzue T, Kawano Y, Takaue Y, Kuroda Y. Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor. Exp Hematol 1994;22:888-92.
7. Bensinger WI, Price TH, Dale DC, et al. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood 1993;81:1883-8.
8. Russell JA, Luider J, Weaver M, et al. Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 1995;15:111-5.
9. Stroncek D, Clay M, Mills B, et al. Experiences of normal individuals treated with granulocyte colony stimulating factor (abstract). Blood 1994;84:349a.
10. Dreger P, Haferlach T, Eckstein V, et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 1994;87:609-13.
11. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995;86:2842-8.
12. NCI common toxicity criteria. Bethesda: National Cancer Institute, Division of Cancer Treatment, 1988.
13. Buckner CD, Clift RA, Sanders JE, et al. Marrow harvesting from normal donors. Blood 1984;64:630-4.
14. Petersen FB, Buckner CD, Bolonesi B, et al. Marrow harvesting from normal donors (abstract). Exp Hematol 1990;18:676.
15. Lindemann A, Herrmann F, Oster W, et al. Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood 1989;74:2644-51.
16. Comenzo RL, Malachowski ME, Miller KB, et al. Engraftment with peripheral blood stem cells collected by large-volume leukapheresis for patients with lymphoma. Transfusion 1992;32:729-31.
17. Hillyer CD, Tiegerman KO, Berkman EM. Increase in circulating colony-forming units-granulocyte-macrophage during large-volume leukapheresis: evaluation of a new cell separator. Transfusion 1991;31:327-32.
18. Fosså SD, Poulsen JP, Aaserud A. Alkaline phosphatase and lactate dehydrogenase changes during leucocytosis induced by G-CSF in testicular cancer (letter). Lancet 1992;340:1544.
19. Maiche AG, Muhonen T, Porkka K. Lactate dehydrogenase changes during granulocyte colony-stimulating factor treatment (letter). Lancet 1992;340:853.
20. Bonilla MA, Dale D, Zeidler C, et al. Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol 1994;88:723-30.
21. Gibson RN, Hennessy OF, Collier N, Hemingway AP. Major complications of central venous catheterisation: a report of five cases and a brief review of the literature. Clin Radiol 1985;36:205-8.
22. Höglund M, Bengtsson M, Simonsson B, et al. Leukapheresis with peripheral blood progenitor cell (PBPC) harvest in healthy volunteers receiving different doses of Lenograstim - evidence of a dose response effect (abstract). Blood 1994;84:348a.